Docetaxel With Bevacizumab as First-Line Therapy in Treating Women With Stage IV Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: BIOLOGICAL: bevacizumab|DRUG: Docetaxel
Sponsor: Translational Oncology Research International
Collaborators: University of California, Los Angeles